Sectors
MTNB
Matinas BioPharma Holdings, Inc.
0.19
2500 x 0.19
500 x 0.20
bid
ask
-
0.01
3.70%
10:28 AM
timesize
| Ytd | -67.13% | |
| 1y | -89.42% |
0.19
day range
0.20
0.18
52 week range
2.14
| Open | 0.19 | Prev Close | 0.20 | Low | 0.19 | High | 0.20 | Mkt Cap | 2.83M |
| Vol | 97.20K | Avg Vol | 5.47M | EPS | -1.15 | P/E | N/A | Forward P/E | -0.17 |
| Beta | 1.76 | Short Ratio | 0.19 | Inst. Own | 26.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.38 | 200-d Avg | 0.60 | 1yr Est | 30.00 |
| Income Statement | |||
| Operating Expenses | 1.69M | ||
| Selling, General and Administrative Expense | 1.56M | ||
| Operating Income | -1.69M | ||
| Net Income | -1.33M | ||
| Net Income Common Stock | -1.33M | ||
| Net Income Common Stock (USD) | -1.33M | ||
| Consolidated Income | -1.33M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -1.33M | ||
| Earning Before Interest & Taxes (USD) | -1.33M | ||
| Weighted Average Shares | 6.41M | ||
| Weighted Average Shares Diluted | 6.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 761.00K | ||
| Cash and Equivalents (USD) | 761.00K | ||
| Investments | 50.00K | ||
| Investments Current | 50.00K | ||
| Current Assets | 1.14M | ||
| Property, Plant & Equipment Net | 9.00K | ||
| Total Assets | 3.41M | ||
| Debt Current | 1000 | ||
| Total Debt | 6.00K | ||
| Current Liabilities | 1.35M | ||
| Debt Non-Current | 5.00K | ||
| Total Liabilities | 1.61M | ||
| Accumulated Retained Earnings (Deficit) | -214.03M | ||
| Shareholders Equity | 1.80M | ||
| Shareholders Equity (USD) | 1.80M | ||
| Assets Non-Current | 2.27M | ||
| Total Debt (USD) | 6.00K | ||
| Liabilities Non-Current | 262.00K | ||
| Trade and Non-Trade Payables | 845.00K | ||
| Tax Liabilities | 257.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -74.00K | ||
| Net Cash Flow from Financing | -1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.84M | ||
| Issuance (Repayment) of Debt Securities | -1000 | ||
| Net Cash Flow from Operations | -1.84M | ||
| Share Based Compensation | 104.00K | ||